Yu Min Kang, Noh Hyuck Park, Min Jae Seong, Hyun Jeong Han, Young Hee Jung
{"title":"1例COVID-19患者脑MRI多发强化病灶","authors":"Yu Min Kang, Noh Hyuck Park, Min Jae Seong, Hyun Jeong Han, Young Hee Jung","doi":"10.12779/dnd.2021.20.2.13","DOIUrl":null,"url":null,"abstract":"A 67-year-old-male was hospitalised for COVID-19-associated-pneumonia on April 2, 2020. His first symptoms consisted of myalgia and a cough. COVID-19 was diagnosed based on the detection of SARS-CoV-2 viral nucleic acid through a nasopharyngeal swab specimen using real-time polymerase-chain-reaction assay. Chest computerised tomography showed patchy areas of consolidation in the peribronchial and subpleural areas of both lungs, which was consistent with COVID-19-associated-pneumonia. He had diabetes, chronic kidney disease without dialysis, and alcoholic liver disease. The patient was not a smoker, but a heavy drinker. Lopinavir/ritonavir and antibiotic therapy were initiated. On the 5th day of illness, the patient was intubated due to desaturation. On the 14th day, multi-organ failure was diagnosed, and continuous-renal-replacement-therapy and extracorporeal-membraneoxygenation were administered. On the 25th day, he was released from quarantine due to the negative results of three consecutive COVID-19-tests. He had stupor, but diffusion, and MRI showed no abnormal findings. The response was not improved until 42nd day, although sedative was not used.","PeriodicalId":72779,"journal":{"name":"Dementia and neurocognitive disorders","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1b/0b/dnd-20-13.PMC8093011.pdf","citationCount":"0","resultStr":"{\"title\":\"Multiple Enhanced Lesions in the Brain MRI of a Patient with COVID-19.\",\"authors\":\"Yu Min Kang, Noh Hyuck Park, Min Jae Seong, Hyun Jeong Han, Young Hee Jung\",\"doi\":\"10.12779/dnd.2021.20.2.13\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A 67-year-old-male was hospitalised for COVID-19-associated-pneumonia on April 2, 2020. His first symptoms consisted of myalgia and a cough. COVID-19 was diagnosed based on the detection of SARS-CoV-2 viral nucleic acid through a nasopharyngeal swab specimen using real-time polymerase-chain-reaction assay. Chest computerised tomography showed patchy areas of consolidation in the peribronchial and subpleural areas of both lungs, which was consistent with COVID-19-associated-pneumonia. He had diabetes, chronic kidney disease without dialysis, and alcoholic liver disease. The patient was not a smoker, but a heavy drinker. Lopinavir/ritonavir and antibiotic therapy were initiated. On the 5th day of illness, the patient was intubated due to desaturation. On the 14th day, multi-organ failure was diagnosed, and continuous-renal-replacement-therapy and extracorporeal-membraneoxygenation were administered. On the 25th day, he was released from quarantine due to the negative results of three consecutive COVID-19-tests. He had stupor, but diffusion, and MRI showed no abnormal findings. The response was not improved until 42nd day, although sedative was not used.\",\"PeriodicalId\":72779,\"journal\":{\"name\":\"Dementia and neurocognitive disorders\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1b/0b/dnd-20-13.PMC8093011.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Dementia and neurocognitive disorders\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12779/dnd.2021.20.2.13\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/4/8 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dementia and neurocognitive disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12779/dnd.2021.20.2.13","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/4/8 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
Multiple Enhanced Lesions in the Brain MRI of a Patient with COVID-19.
A 67-year-old-male was hospitalised for COVID-19-associated-pneumonia on April 2, 2020. His first symptoms consisted of myalgia and a cough. COVID-19 was diagnosed based on the detection of SARS-CoV-2 viral nucleic acid through a nasopharyngeal swab specimen using real-time polymerase-chain-reaction assay. Chest computerised tomography showed patchy areas of consolidation in the peribronchial and subpleural areas of both lungs, which was consistent with COVID-19-associated-pneumonia. He had diabetes, chronic kidney disease without dialysis, and alcoholic liver disease. The patient was not a smoker, but a heavy drinker. Lopinavir/ritonavir and antibiotic therapy were initiated. On the 5th day of illness, the patient was intubated due to desaturation. On the 14th day, multi-organ failure was diagnosed, and continuous-renal-replacement-therapy and extracorporeal-membraneoxygenation were administered. On the 25th day, he was released from quarantine due to the negative results of three consecutive COVID-19-tests. He had stupor, but diffusion, and MRI showed no abnormal findings. The response was not improved until 42nd day, although sedative was not used.